ArticleCardiovascular diabetology2025
Association between the stress hyperglycemia ratio and elevated blood pressure among U.S. adolescents aged 12-17.
Article in Cardiovascular diabetology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundThe stress hyperglycemia ratio (SHR) has been reported to be closely associated with various diseases and prognoses. However, the relationship between SHR and elevated blood pressure (EBP) in adolescents aged 12-17 remains unclear.
methodsThis cross-sectional study included U.S. adolescents from the 1999-2016 National Health and Nutrition Examination Survey (NHANES). The primary outcome was EBP. SHR was calculated by the formula [FPG (mmol/L)] / [1.59 × HbA1c (%) - 2.59]. Patients were divided into SHR quartiles. Weighted multivariable logistic regression models, subgroup analysis, restricted cubic spline (RCS) and receiver operating characteristic (ROC) curves, sensitivity analyses were used to evaluate the associations.
resultsA total of 3676 participants were included. Among them, 543 participants had EBP. In the fully adjusted model (Model 3), per SD increase in SHR was associated with a 17% higher odds of EBP (aOR 1.17, 95%CI 1.04-1.32, p = 0.009). Compared with the lowest quartile, participants in the highest quartile had a 95% higher odds of EBP (aOR 1.90, 95%CI 1.29-2.79, p for trend < 0.001). RCS analysis revealed a significant linear association between SHR and EBP (p for non-linearity > 0.05). ROC curves indicated that SHR had modest predictive performance for EBP in adolescents (AUC 0.723, 95%CI 0.699-0.747).
conclusionsThis study suggests that higher SHR levels are positively associated with the prevalence of EBP among U.S. adolescents aged 12-17.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.